REDCARE PHARMACY NV (RDC.DE) Fundamental Analysis & Valuation

FRA:RDC • NL0012044747

Current stock price

48.4 EUR
+0.5 (+1.04%)
Last:

This RDC.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. RDC.DE Profitability Analysis

1.1 Basic Checks

  • RDC had negative earnings in the past year.
  • RDC had a positive operating cash flow in the past year.
  • RDC had negative earnings in each of the past 5 years.
  • RDC had a positive operating cash flow in 4 of the past 5 years.
RDC.DE Yearly Net Income VS EBIT VS OCF VS FCFRDC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

  • The Return On Assets of RDC (-3.10%) is worse than 80.95% of its industry peers.
  • RDC has a Return On Equity of -8.21%. This is amonst the worse of the industry: RDC underperforms 80.95% of its industry peers.
Industry RankSector Rank
ROA -3.1%
ROE -8.21%
ROIC N/A
ROA(3y)-2.94%
ROA(5y)-5.79%
ROE(3y)-6.64%
ROE(5y)-11.93%
ROIC(3y)N/A
ROIC(5y)N/A
RDC.DE Yearly ROA, ROE, ROICRDC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20

1.3 Margins

  • RDC has a Gross Margin (22.57%) which is in line with its industry peers.
  • RDC's Gross Margin has been stable in the last couple of years.
  • RDC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.42%
GM growth 5Y-0.09%
RDC.DE Yearly Profit, Operating, Gross MarginsRDC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. RDC.DE Health Analysis

2.1 Basic Checks

  • RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • RDC has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for RDC has been increased compared to 5 years ago.
  • Compared to 1 year ago, RDC has a worse debt to assets ratio.
RDC.DE Yearly Shares OutstandingRDC.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
RDC.DE Yearly Total Debt VS Total AssetsRDC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • RDC has an Altman-Z score of 2.99. This is not the best score and indicates that RDC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • RDC's Altman-Z score of 2.99 is in line compared to the rest of the industry. RDC outperforms 47.62% of its industry peers.
  • A Debt/Equity ratio of 0.72 indicates that RDC is somewhat dependend on debt financing.
  • The Debt to Equity ratio of RDC (0.72) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z 2.99
ROIC/WACCN/A
WACC6.26%
RDC.DE Yearly LT Debt VS Equity VS FCFRDC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • RDC has a Current Ratio of 1.55. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Current ratio value of 1.55, RDC belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • A Quick Ratio of 1.01 indicates that RDC should not have too much problems paying its short term obligations.
  • RDC has a better Quick ratio (1.01) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.01
RDC.DE Yearly Current Assets VS Current LiabilitesRDC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. RDC.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.77% over the past year.
  • Looking at the last year, RDC shows a very strong growth in Revenue. The Revenue has grown by 24.06%.
  • RDC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.89% yearly.
EPS 1Y (TTM)17.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.7%
Revenue 1Y (TTM)24.06%
Revenue growth 3Y34.66%
Revenue growth 5Y24.89%
Sales Q2Q%17.75%

3.2 Future

  • Based on estimates for the next years, RDC will show a very strong growth in Earnings Per Share. The EPS will grow by 54.84% on average per year.
  • RDC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.84% yearly.
EPS Next Y80.18%
EPS Next 2Y71.98%
EPS Next 3Y61.59%
EPS Next 5Y54.84%
Revenue Next Year14.87%
Revenue Next 2Y13.62%
Revenue Next 3Y12.42%
Revenue Next 5Y11.84%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RDC.DE Yearly Revenue VS EstimatesRDC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RDC.DE Yearly EPS VS EstimatesRDC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. RDC.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RDC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDC.DE Price Earnings VS Forward Price EarningsRDC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, RDC is valued a bit more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.17
RDC.DE Per share dataRDC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • A more expensive valuation may be justified as RDC's earnings are expected to grow with 61.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.98%
EPS Next 3Y61.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RDC.DE Dividend Analysis

5.1 Amount

  • No dividends for RDC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RDC.DE Fundamentals: All Metrics, Ratios and Statistics

REDCARE PHARMACY NV

FRA:RDC (4/30/2026, 7:00:00 PM)

48.4

+0.5 (+1.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Industry Strength1.35
Industry Growth61.33
Earnings (Last)03-03
Earnings (Next)05-06
Inst Owners46.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap996.07M
Revenue(TTM)2.94B
Net Income(TTM)-37.70M
Analysts77.5
Price Target95.46 (97.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.52%
Min EPS beat(2)-108.23%
Max EPS beat(2)-12.8%
EPS beat(4)2
Avg EPS beat(4)54.9%
Min EPS beat(4)-108.23%
Max EPS beat(4)313.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-1.9%
Max Revenue beat(2)-1.55%
Revenue beat(4)0
Avg Revenue beat(4)-1.34%
Min Revenue beat(4)-1.9%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-27.3%
PT rev (3m)-30.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-309.52%
EPS NY rev (3m)-249.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.03%
Revenue NY rev (3m)-4.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF 32.13
P/B 2.17
P/tB 15.16
EV/EBITDA 23.17
EPS(TTM)-1.49
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-4.26
FCFYN/A
OCF(TTM)1.51
OCFY3.11%
SpS142.9
BVpS22.31
TBVpS3.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -3.1%
ROE -8.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.57%
FCFM N/A
ROA(3y)-2.94%
ROA(5y)-5.79%
ROE(3y)-6.64%
ROE(5y)-11.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.42%
GM growth 5Y-0.09%
F-Score4
Asset Turnover2.42
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA 6.97
Cap/Depr 170.89%
Cap/Sales 4.03%
Interest Coverage N/A
Cash Conversion 65.4%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.01
Altman-Z 2.99
F-Score4
WACC6.26%
ROIC/WACCN/A
Cap/Depr(3y)99.8%
Cap/Depr(5y)118.99%
Cap/Sales(3y)2.65%
Cap/Sales(5y)3.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.7%
EPS Next Y80.18%
EPS Next 2Y71.98%
EPS Next 3Y61.59%
EPS Next 5Y54.84%
Revenue 1Y (TTM)24.06%
Revenue growth 3Y34.66%
Revenue growth 5Y24.89%
Sales Q2Q%17.75%
Revenue Next Year14.87%
Revenue Next 2Y13.62%
Revenue Next 3Y12.42%
Revenue Next 5Y11.84%
EBIT growth 1Y42.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year765.43%
EBIT Next 3Y146.02%
EBIT Next 5Y83.87%
FCF growth 1Y-337.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.11%
OCF growth 3YN/A
OCF growth 5Y11.73%

REDCARE PHARMACY NV / RDC.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of REDCARE PHARMACY NV (RDC.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE.


Can you provide the valuation status for REDCARE PHARMACY NV?

ChartMill assigns a valuation rating of 1 / 10 to REDCARE PHARMACY NV (RDC.DE). This can be considered as Overvalued.


What is the profitability of RDC stock?

REDCARE PHARMACY NV (RDC.DE) has a profitability rating of 1 / 10.


What is the earnings growth outlook for REDCARE PHARMACY NV?

The Earnings per Share (EPS) of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 80.18% in the next year.